TPW 6.03 Cost Analysis of Same-Admission Versus Delayed Cholecystectomy: Total Pathway Costs in Acute Biliary Pancreatitis Management
British Journal of Surgery · 05.08.2026 · 113 (Supplement_8)
DOI: 10.1093/bjs/znag087.356 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 05.08.2026. Verfasst von Bhavesh Devkaran und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
NICE-guidance NG104 emphasizes timely, definitive management of acute pancreatitis. Same-admission cholecystectomy reduces recurrence and multiple-admissions, yet local implementation remains suboptimal. This analysis examines the economic implications of current practice variations.
Methods
We reviewed 950 admissions (806 patients) with acute biliary pancreatitis (2017-2023), comparing same-admission cholecystectomy (159 cases, 17%) with delayed surgery (384 cases) at our busy tertiary University-HPB Centre in the North-West of England. Costs were calculated using NHS-reference-rates (£400/bed-day, £3,500/surgery), excluding outpatient-care and indirect costs.
Results
Same-admission surgery patients completed treatment in one 8.7-day stay costing £9,728. Delayed surgery required two admissions (6.1 days initial, 4 days surgical) after a median 99-day wait, totalling £10,317—£589 more per patient. This extended interval may reflect system-level barriers, including theatre-availability constraints and inefficiencies in the pathway. Multiple-admissions (13.8% of patients) generated £1.18 million (20.4% of total costs). Among 83 delayed-surgery patients experiencing recurrence, costs totalled £988,158 versus projected £549,660 for same-admission approach—£438,498 savings (£5,283/patient). These potentially preventable recurrences suggest systematic delays in definitive management contrary to evidence-based recommendations. Conservative estimates exclude emergency reattendances, primary-care consultations during waiting periods, and patient morbidity costs, thereby substantially understating the true economic-burden.
Conclusions
Same-admission cholecystectomy yields £589 per-patient savings and prevents costly recurrences. The current 17% same-admission rate represents significant underutilization requiring organizational attention. Increasing rates to 40% for 150 annual patients could save £35,000 yearly while reducing preventable morbidity. Implementation requires addressing service delivery gaps by prioritizing theatre access, streamlining assessments, and enhancing interdisciplinary coordination to align local practice with national guidance.
Zitieren
APA
Devkaran, B., Kyriakides, R., Taylor, J., Shahzad, K., Mishra, N., & Sharma, H. (2026). TPW 6.03 Cost Analysis of Same-Admission Versus Delayed Cholecystectomy: Total Pathway Costs in Acute Biliary Pancreatitis Management. British Journal of Surgery, 113(Supplement_8). https://doi.org/10.1093/bjs/znag087.356
Vancouver
Devkaran B, Kyriakides R, Taylor J, Shahzad K, Mishra N, Sharma H. TPW 6.03 Cost Analysis of Same-Admission Versus Delayed Cholecystectomy: Total Pathway Costs in Acute Biliary Pancreatitis Management. British Journal of Surgery. 2026;113(Supplement_8). doi:10.1093/bjs/znag087.356
BibTeX
@article{Devkaran2026,
author = {Devkaran, Bhavesh and Kyriakides, Rena and Taylor, John and Shahzad, Khalid and Mishra, Nikhil and Sharma, Hemant},
title = {TPW 6.03 Cost Analysis of Same-Admission Versus Delayed Cholecystectomy: Total Pathway Costs in Acute Biliary Pancreatitis Management},
journal = {British Journal of Surgery},
year = {2026},
volume = {113},
number = {Supplement_8},
doi = {10.1093/bjs/znag087.356}
}
EUVIMED